Endocrinology. Dynamic assays of inhibin B and oestradiol following buserelin acetate administration as predictors of ovarian response in IVF
Source: Human Reproduction, Volume 15, Number 11, November 2000 , pp. 2297-2301(5)
Publisher: Oxford University Press
Abstract:The study was designed to examine whether dynamic measurements of inhibin B and oestradiol following single administration of buserelin acetate were correlated with the ovarian response to stimulation in IVF. A total of 37 patients undergoing IVF treatment was studied when the long protocol was started in the early follicular phase. Blood samples were taken twice: on day 2 of the menstrual cycle, before the first s.c. administration of buserelin acetate 0.5 mg and on day 3, 24 h later. Inhibin B and oestradiol concentrations were compared with the ovarian response to stimulation. The ovarian response was defined in two ways: `number of oocytes/total recombinant (r) follicle stimulating hormone (FSH) dose'; and `square-root (number of follicles/total rFSH dose)'. The following measurements were highly correlated with the ovarian response to stimulation: increase in oestradiol (day 3–day 2 oestradiol concentration) [correlation coefficient (r) = 0.68, P < 0.0001] and sum of inhibin B (day 2 + day 3 inhibin B concentrations) (r = 0.6, P < 0.0001). Age and basal concentrations of FSH and inhibin B were inferior to the above measurements in terms of correlation with the ovarian response. In conclusion, dynamic measurements of inhibin B and oestradiol following single administration of buserelin acetate were highly correlated with the ovarian response to stimulation for IVF treatment.
Document Type: Research Article
Affiliations: 1: IVF Unit, Department of Reproductive Medicine and Science 2: Department of Paediatrics, Obstetrics and Gynaecology and 3: Department of Clinical Chemistry, Imperial College School of Medicine, Hammersmith Hospital, London, UK
Publication date: 2000-11-01
- Human Reproduction features full-length, peer-reviewed papers reporting original research, clinical case histories, as well as opinions and debates on topical issues. Papers published cover the scientific and medical aspects of reproductive physiology and pathology, endocrinology, andrology, gonad function, gametogenesis, fertilization, embryo development, implantation, pregnancy, genetics, genetic diagnosis, oncology, infectious disease, surgery, contraception, infertility treatment, psychology, ethics and social issues. The highest scientific and editorial standard is maintained throughout the journal along with a rapid rate of publication.